ABBV · News · 20260921N

Product / Drug Pipeline Progress

AbbVie Inc. · 2026-09-21 · Importance 31 · Surprise 42

AbbVie and Iambic entered a multi-year collaboration to apply Iambic’s AI platform to small-molecule drug discovery. The work will focus on immunology, neuroscience, and oncology, using Iambic’s Enchant and NeuralPLexer technologies alongside AbbVie’s therapeutic expertise. The companies expect the platform to shorten drug-discovery timelines and improve the identification of drug candidates and potential medicines.